BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38318446)

  • 1. Serum Metrnl is Decreased in Metabolic Dysfunction-Associated Fatty Liver Disease: A Case-Control Study.
    Liu M; Gao X; Tian Y; Li H; Yin Z; Han L; Zhang L
    Diabetes Metab Syndr Obes; 2024; 17():533-543. PubMed ID: 38318446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease.
    Duan SJ; Ren ZY; Zheng T; Peng HY; Niu ZH; Xia H; Chen JL; Zhou YC; Wang RR; Yao SK
    World J Gastroenterol; 2022 Sep; 28(36):5364-5379. PubMed ID: 36185625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum Meteorin-like levels in patients with hyperthyroidism.
    Wen X; Ding X; Chang X; Wang J; Wang Q; Liu J; Wang G
    BMC Endocr Disord; 2022 Dec; 22(1):304. PubMed ID: 36476346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.
    Liu Z; He H; Dai Y; Yang L; Liao S; An Z; Li S
    Lipids Health Dis; 2022 Jun; 21(1):55. PubMed ID: 35752830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.
    Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z
    Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults.
    Li H; Zhang Y; Luo H; Lin R
    Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus.
    Yang J; Li CW; Zhang JR; Qiu H; Guo XL; Wang W
    Diabetes Metab Syndr Obes; 2023; 16():1953-1965. PubMed ID: 37405319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile.
    Ding X; Chang X; Wang J; Bian N; An Y; Wang G; Liu J
    Front Endocrinol (Lausanne); 2022; 13():938341. PubMed ID: 36133314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of TG/HDL-C Combined with Liver Function Indexes to Predict Metabolic-Associated Fatty Liver Disease].
    Xia JX; Zhao YH; He H; Liang SS; Gan W; Li GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):764-769. PubMed ID: 36224676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran.
    Taheri E; Moslem A; Mousavi-Jarrahi A; Hatami B; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
    Gastroenterol Hepatol Bed Bench; 2021; 14(Suppl1):S102-S111. PubMed ID: 35154609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 12. Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.
    Xing Y; Chen J; Liu J; Ma H
    Diabetes Metab Syndr Obes; 2022; 15():383-394. PubMed ID: 35177915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities.
    Pan J; Li Q; Sun Y; Gu Y; Ding Y; Pang N; Zhou Y; Pei L; Gao M; Ma S; Xiao Y; Wu F; Hu D; Chen YM; Yang L
    Diabetes Metab Syndr Obes; 2023; 16():187-200. PubMed ID: 36760590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Metrnl is associated with the presence and severity of coronary artery disease.
    Liu ZX; Ji HH; Yao MP; Wang L; Wang Y; Zhou P; Liu Y; Zheng XF; He HW; Wang LS; Gao W; Lu X
    J Cell Mol Med; 2019 Jan; 23(1):271-280. PubMed ID: 30394666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.
    Xing M; Ni Y; Zhang Y; Zhao X; Yu X
    Front Nutr; 2023; 10():1246157. PubMed ID: 38024359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic profiles and body composition of lean metabolic associated fatty liver disease.
    Cheng YM; Kao JH; Wang CC
    Hepatol Int; 2021 Apr; 15(2):405-412. PubMed ID: 33539004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
    Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
    Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
    Xia B; He H; Qin K; Li SQ; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of variabilities in body mass index and waist circumference with newly achieved remission of metabolic dysfunction-associated fatty liver disease.
    Sogabe M; Okahis T; Kagawa M; Sei M; Ueda H; Yokoyama R; Kagemoto K; Tanaka H; Kida Y; Nakamura F; Tomonari T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
    Diabetes Metab Syndr; 2024 May; 18(5):103036. PubMed ID: 38754333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.